Search over 3,000 reports

    Exondys 51- Drug Insight, 2017

    Exondys 51- Drug Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0085
    "Exondys 51 - Drug Insight, 2018" report by DelveInsight provides comprehensive information of the drug, Exondys 51. It includes Exondys 51`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Exondys 51`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Exondys 51 till 2020. The report also throws light on Exondys 51`s market competition and emerging therapies in the same space as Exondys 51. A SWOT analysis of Exondys 51 is also featured.
    * Depending on information availability

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
    • Patent information around Exondys 51 in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Exondys 51 in United States, Europe, China and India
    • The report contains historical and forecasted sales for Exondys 51 till 2020
    • Comprehensive coverage of the emerging therapies (Phase III) in the space where Exondys 51 operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
    • The report also features the SWOT analysis of Exondys 51

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Exondys 51
    • Access to Exondys 51`s API manufacturers details to devise API procurement strategy for generic development
    • Plan developmental timelines around Exondys 51`s patents for the major markets- US and EU
    • Understand Exondys 51`s current and future growth through its historical and forecasted sales
    • Identify and understand the current in-market competitors for Exondys 51
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify and plan ahead for prospective emerging players and their products operating in the same space as Exondys 51
    • Identify opportunities in the same area as Exondys 51 with DelveInsight`s SWOT analysis
    1. Report Introduction
    2. Exondys 51 - Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Clinical Trials
    • Regulatory Milestones
    • Product Development Activities
    3. Global API Manufacturers
    • United States
    • Europe
    • China
    • India
    4. Product Details
    • United States
    • Europe
    5. Exondys 51 Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    6. Patent Details
    7. Market Competition
    8. Emerging Therapies
    8.1. Drug name: Company name
    • Product Description
    • Research & Development
    • Product Development Activities
    Other product profiles in the detailed report…..
    9. SWOT Analysis
    Consulting Services
    About DelveInsight
    Contact Us
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Exondys 51, Description
    Table 2: API Manufacturers Region wise
    Table 3: API Manufacturers for United States
    Table 4: API Manufacturers for Europe
    Table 5: API Manufacturers for China
    Table 6: API Manufacturers for India
    Table 7: Exondys 51 Product Details, United States
    Table 8: Exondys 51 Product Details, Europe
    Table 9: Exondys 51, Historical Global Sales till 2017 (in million USD)
    Table 10: Exondys 51, Forecasted Global Sales from 2018-2020 (in million USD)
    Table 11: Patent Details: Exondys 51
    Table 12: Exondys 51 Major Competitors
    Table 13: Emerging Therapies
    Figure 1: Exondys 51
    Figure 2: Exondys 51, Historical Global Sales till 2017 (in million USD)
    Figure 3: Exondys 51, Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Exondys 51
    Figure 5: API Manufacturers Region wise
    Exondys 51

    Exondys 51 Marketed Drugs Overview

    Exondys 51 Market Assessment

    Exondys 51 API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Exondys 51 US DMF

    Exondys 51 US Drug Master Files

    Exondys 51 Active Substance Master File/ EUDMF

    Exondys 51 Generic players

    Exondys 51 Patent Expiration

    Exondys 51 Patent Exclusivity

    Exondys 51 API Manufacturers

    Exondys 51 Global Forecasted Sales Figure

    Exondys 51 API Route of Synthesis

    Exondys 51 Market sales

    Exondys 51 SWOT Analysis

    Exondys 51 Pipeline

    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap